Tyra Biosciences, Inc.
TYRA
$25.38
$0.361.42%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 14.99% | 2.38% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 16.68% | 15.01% | |||
| Operating Income | -16.68% | -15.01% | |||
| Income Before Tax | -15.91% | -16.17% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -15.91% | -16.17% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -15.91% | -16.17% | |||
| EBIT | -16.68% | -15.01% | |||
| EBITDA | -16.73% | -15.05% | |||
| EPS Basic | -8.45% | -12.57% | |||
| Normalized Basic EPS | -8.47% | -12.56% | |||
| EPS Diluted | -8.45% | -12.57% | |||
| Normalized Diluted EPS | -8.47% | -12.56% | |||
| Average Basic Shares Outstanding | 6.88% | 3.19% | |||
| Average Diluted Shares Outstanding | 6.88% | 3.19% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||